Table 2.
Symptoms and Medication | Initial Dose | Target Dose | Common or Serious Side Effects | Evidence | FDA-Approved | ||
---|---|---|---|---|---|---|---|
Constipation | mg/day† | For the Symptom | For IBS | For the Symptom | For IBS | ||
Laxatives‡ and secretory stimulators | |||||||
Polyethylene glycol 3350 (Miralax, Braintree Labs) | 17,000 | up to 34,000, twice a day | Diarrhea, bloating, cramping | +++ | − | ||
Lactulose (Kristalose, Cumberland Pharmaceuticals) | 10,000–20,000 | 20,000–40,000 | Diarrhea, bloating, cramping | +++ | − | ||
Lubiprostone (Amitiza; Takeda, Sucampo) | 24 µg, twice a day | Nausea, diarrhea, headache, abdominal pain and discomfort | +++ | − | Yes§ | No | |
Prokinetics | |||||||
Tegaserod (Zelnorm, Novartis) | 6, twice a day | Initial diarrhea, abdominal pain, cardiovascular ischemia (rare) | +++ | +++ | Yes¶ | Yes¶ | |
Diarrhea | |||||||
Loperamide (Imodium, McNeil) | 2 | 2–8 | Constipation | +++ | − | Yes | No |
Alosetron (Lotronex, GlaxoSmithKline)‖ | 0.5, twice a day | up to 1, twice a day | Constipation, ischemic colitis (rare) | − | +++ | No | Yes |
Bloating | |||||||
Antibiotics | |||||||
Rifaximin (Salix) | 400, three times a day | Abdominal pain, diarrhea, bad taste | − | + | No | No | |
Probiotics** | |||||||
Bifidobacterium infantis 35624 (Align, Procter & Gamble) | 1 capsule per day | None | + | + | No | No | |
Pain | |||||||
Tricyclic antidepressants†† | Dry mouth, dizziness, weight gain | ||||||
Amitriptyline | 10, at bedtime | 10–75, at bedtime | ++ | + | No | No | |
Desipramine | 10, at bedtime | 10–75, at bedtime | ++ | + | No | No | |
Selective serotonin-reuptake inhibitors‡‡ | Sexual dysfunction, headache, nausea, sedation, insomnia, sweating, withdrawal symptoms | ||||||
Paroxetine (Paxil CR, GlaxoSmithKline) | 10–60 | − | + | No | No | ||
Citalopram (Lexapro, Forest) | 5–20 | + | + | No | No | ||
Fluoxetine (Prozac, Eli Lilly) | 20–40 | Somnolence, dizziness, headaches, insomnia | + | − | No | No |
This list is not exhaustive but includes major medications for which there is evidence from well-designed clinical trials of effectiveness for global IBS symptoms or for individual symptoms (e.g., constipation, diarrhea, or abdominal pain and discomfort). In the columns about evidence, + denotes some evidence from at least one controlled trial, ++ moderate evidence from several controlled trials or from meta-analysis of such trials, +++ strong evidence from well-designed, controlled clinical trials, and − no evidence. FDA denotes Food and Drug Administration.
Dosages are in milligrams per day unless otherwise noted.
A wide range of osmotic and irritant laxatives, including fiber products, are available over the counter.
Lubiprostone is FDA-approved for the treatment of chronic constipation.
Marketing of tegaserod was suspended by the FDA in March 2007 because of rare cardiovascular side effects but is now available as part of a restricted-access program for women who have constipation-predominant IBS or chronic idiopathic constipation, without known or preexisting heart problems, that is unresponsive to other medications.21
Alosetron use is restricted to women with severe diarrhea-predominant IBS, unresponsive to other medications, owing to side effects.
Many probiotics are available over the counter and are not listed. Align is a probiotic for which a beneficial effect for IBS symptoms has been shown in a high-quality, randomized, controlled trial.
A wide range of tricyclic antidepressants with various side effects and side-effect profiles is available. Two commonly prescribed tricyclic antidepressants are listed. The doses listed are based on clinical experience.
Many selective serotonin-reuptake inhibitors are available. Only those that have been evaluated in IBS trials are listed. Also not listed are serotonin–norepinephrine reuptake inhibitors.